Panacea Life Sciences Holdings, Inc. (PLSH): Capital Expenditures
Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$65.3K
Year ended 2023-12-31
-72.7%
3-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $65.3K | -73.2% | 2024-04-01, From 2023-01-01 |
| 2022-12-31 | $243.8K | +49.6% | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $162.9K | -94.9% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $3.20M | +491.3% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $541.2K | n/a | 2021-04-23, From 2019-01-01 |
| 2018-12-31 | $0 | n/a | 2020-05-22, From 2018-01-01 |
| No annual figure between 2016-12-31 and 2018-12-31. | |||
| 2016-12-31 | -$1.3K | n/a | 2017-03-31, From 2016-01-01 |
| 2015-12-31 | $0 | -100.0% | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | $6.0K | n/a | 2016-02-29, From 2014-01-01 |